Infinium Pharmachem

287.90
-15.15
(-5.00%)
Market Cap
448.60 Cr
EPS
8.12
PE Ratio
55.05
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
392.50
52 Week Low
178.05
PB Ratio
4.10
Debt to Equity
0.50
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,677.60
#1 4,02,512.40
35.10
#1 49,887.20
12.06
#1 9,648
-18.99
42.28
6,612.00
1,75,527.80
80.12
8,184.00
0.89
1,600
23.05
63.47
1,465.70
1,18,372.10
22.44
26,520.70
14.17
4,155
30.28
44.20
3,174.70
1,07,446.30
55.71
10,785.70
11.59
1,656
10.91
44.55
1,251.20
1,04,407.10
#1 18.47
28,905.40
12.36
5,578
21.14
67.52
2,467.70
1,01,812.00
51.37
10,615.60
19.57
1,942
-10.91
48.86
930.00
93,579.80
20.04
19,831.50
13.82
3,831
-0.19
63.14
1,957.70
89,377.00
27.25
20,141.50
#1 19.94
1,936
#1 112.49
43.05
1,147.80
66,664.40
19.29
29,559.20
17.55
3,169
-0.50
43.00
30,455.00
64,714.70
45.75
6,097.20
10.80
1,201
27.83
50.48
Forecast
Actual
Growth Rate
Revenue Growth
18.69 %
Net Income Growth
17.35 %
Cash Flow Change
-251.80 %
ROE
-53.73 %
ROCE
-46.09 %
EBITDA Margin (Avg.)
-2.79 %

Yearly Financial Results

Annual Financials
2022
2023
2024
TTM
Revenue
100
116
137
0
Expenses
89
98
117
0
EBITDA
11
17
20
0
Operating Profit %
10 %
14 %
14 %
0 %
Depreciation
1
1
3
0
Interest
2
3
2
0
Profit Before Tax
9
13
15
0
Tax
2
3
4
0
Net Profit
7
10
12
0
EPS in ₹
60.07
6.82
8.12
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
59
71
86
Fixed Assets
4
19
20
Current Assets
44
51
65
Capital Work in Progress
9
0
0
Investments
0
0
0
Other Assets
46
52
66
Total Liabilities
59
71
86
Current Liabilities
32
37
17
Non Current Liabilities
14
10
8
Total Equity
14
24
60
Reserve & Surplus
12
18
45
Share Capital
1
5
14

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
1
1
4
1
6
Investing Activities
-1
-5
-7
-5
-4
Operating Activities
3
7
12
9
-13
Financing Activities
-1
-1
-2
-3
23

Share Holding

% Holding
Feb 2023
Mar 2023
Apr 2023
Sept 2023
Mar 2024
Sept 2024
Nov 2024
Mar 2025
Promoter
100.00 %
100.00 %
73.05 %
73.05 %
73.05 %
73.05 %
65.24 %
65.24 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
22.56 %
23.96 %
23.85 %
23.97 %
32.05 %
32.00 %
Others
0.00 %
0.00 %
4.38 %
2.99 %
3.10 %
2.98 %
2.71 %
2.76 %
No of Share Holders
17
17
1,145
646
771
947
998
958

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 280.60 316.25
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 321.25 328.00
23 Oct 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
23 Oct 2024 336.00 308.75
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 195.85 336.00
06 Jul 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
06 Jul 2024 223.00 229.20
13 Sept 2023 BONUS Bonus
1:1
13 Sept 2023 500.55 495.00

Technical Indicators

RSI(14)
Neutral
45.90
ATR(14)
Volatile
13.20
STOCH(9,6)
Neutral
42.46
STOCH RSI(14)
Neutral
20.50
MACD(12,26)
Bearish
-3.31
ADX(14)
Strong Trend
25.03
UO(9)
Bullish
27.29
ROC(12)
Downtrend And Accelerating
-4.03
WillR(14)
Oversold
-100.00